Arcas News
We are very pleased to announce that Dr. Robert Stephan has recently joined The Arcas Group as Director, Medical Services and Strategy. He has already proven to be a great addition to our leadership team.
Rob joins Arcas with more than 15 years of experience in oncology, hematology, and immunology research and continuing medical education program development and implementation, with a specialization in strategic planning and execution.
Focusing on managing and expanding the relationships of Arcas with global and national thoughtleaders in complex disease areas, Rob deepens the clinical and scientific expertise of our team. He will play an instrumental role and be a key driver to support the continued growth of Arcas. Rob’s bio can be viewed here.
August 14th, 2008
The Arcas Group is your partner in addressing strategic and tactical marketing challenges in complex disease areas. We are your go-to resource for leveraged marketing strategies that will enhance your relationships with medical thoughtleaders and physicians. You will gain unrivalled market intellgence and thoughtleader insight through our proprietary program, MDoutlook®.
Learn more about our capabilities and proposition by viewing this one minute video. By clicking on this link, you can download a 2-pg synopsis of our proposition.
We look forward to working with you and growing your business.
The Arcas Group
August 14th, 2008
View your invitation by clicking on the image: 
You are invited to join the MDOUTLOOK Strategy Council to discuss cancer treatment from a clinician’s point of view. Events will be scheduled on 12-15 September at the Stockholm International Fairs, where ESMO is being held. We will accommodate your schedule for convenient meeting times.
We look forward to seeing you at ESMO. For complete details and RSVP, please contact Craig Krugman, Vice President, Client Services & Strategy at +1.404.452.5988, ckrugman@thearcasgroup.com. You can also contact Walter Colasante, Director, European Strategic Development at +44.1638.718460, wcolasante@thearcasgroup.com.
MDOUTLOOK is an exclusive web-based platform that provides a clinical practitioner’s view of the European and United States oncology landscape.
MDOUTLOOK delivers:
· Insight into clinical treatment behavior – with a singular focus on treatment decisions and rationale
· Exclusive access to unique ThoughtLeader driven analysis, intelligence and perspective
· Comprehensive profiles of cancer treaters, ThoughtLeaders and institutions.
The MDOUTLOOK Strategy Council will be on hand to privately discuss the landscape of cancer treatment, and to demonstrate how MDOUTLOOK delivers critical marketing intelligence and insight that will directly contribute to your commercial success.
August 11th, 2008
The Arcas Group is proud to be a sponsor of the upcoming 4th Annual Networking Dinner Reception, which is hosted by John Mack of Pharma Marketing News.
We invite you to join us and over 100 of your colleagues in Princeton, NJ, for an evening of networking, learning and good company. You can find the program agenda and registration details on www.networkreception.pharma-mkting.com.
As our valued business partner, we can offer you a registration discount by using the following code: JANH519.
Looking forward to seeing you in Princeton on June 4.
The Arcas Group
May 28th, 2008
Our mission is to grow your market position. We do this through strategic consulting and management services with a singular focus: improving the connectivity between medical thoughtleaders, physicians and (bio)pharmaceutical companies.
You can download an overview of our capabilities and our unique MDoutlook oncology intelligence offering here: Arcas Capabilities.
Please contact us for an exploratory discussion of how we can add value to your business.
May 15th, 2008
We are inviting you to join the MDOUTLOOK Strategy Council to discuss cancer treatment from a clinician’s point of view. Events are scheduled from 5-8pm between May 30 and June 2 at our ASCO suite, Hilton Chicago, 720 S. Michigan Avenue, Chicago (ASCO Headqaurters).
We look forward to seeing you at ASCO. For complete details and RSVP, please contact Craig Krugman, Vice President, Client Services & Strategy at 404.452.5988, ckrugman@thearcasgroup.com.
MDOUTLOOK is an exclusive web-based platform that provides a clinical practitioner’s view of the United States and European oncology landscape.
MDOUTLOOK delivers:
· Insight into clinical treatment behavior – with a singular focus on treatment decisions and rationale
· Exclusive access to unique ThoughtLeader driven analysis, intelligence and perspective
· Comprehensive profiles of treaters, ThoughtLeaders and institutions The MDOUTLOOK Strategy Council will be on hand to privately discuss the landscape of cancer treatment, and how MDOUTLOOK delivers critical marketing intelligence and insight that will directly contribute to your commercial success.
Your invitation is located here: http://www.thearcasgroup.com/ASCO08/MDoutlook.jpg
May 15th, 2008
Walter Armstrong of Pharmaceutical Executive Magazine has written an interesting article on the outlook for the biopharmaceutical industry in 2008 and the challenges it faces. The article argues that there is a need for fundamental changes within the industry and that, with the new energy and sense of reality found in many C-suites, now is the time to start pursuing them. Most people interviewed for this article (Jan was one of them) agree with this premise, and offer suggested solutions. You can accesss the article via this link.
The solutions involve a continued strong focus on specialty healthcare, with more products for very targeted diseases and, importantly, getting closer to the decision-maker, the physician. Key to accomplishing that is a better understanding of the specialty market place, what therapeutic approaches are taken and why, and what influences the physician decision-making process. This is particularly true in the complex and highly specialized area of oncology.
Our unique oncology intelligence offering, MDoutlook™, has been launched with one goal: improving our clients’ understanding of the global oncology market place. Developed in partnership with Drs. Belani and Scagliotti, MDoutlook™ through proprietary technology and a central web-portal delivers:
- Comprehensive information about oncology clinicians and ThoughtLeaders
- Unique market analytics and intelligence
- Exclusive access to ThoughtLeader analysis and insight.
Peeked your interest?
For more information, visit www.mdoutlook.com or contact us here.
February 27th, 2008
In partnership with Dr Chandra Belani and Dr Giorgio Scagliotti, The Arcas Group is introducing MDoutlook™: a robust and dynamic oncology intelligence platform that will deliver exclusive clinician reported treatment data combined with unique insight and perspective provided by global oncology ThoughtLeaders.
A brief introduction to MDoutlook™:
-
Developed with and guided by prominent global ThoughtLeaders:
-
Chandra Belani, MD, chairs MDoutlook™ United States
-
Giorgio Scagliotti, MD, PhD, chairs MDoutlook™ Europe
-
MDoutlook™ has been developed with a singular focus: improved understanding of the oncology marketplace by delivering comprehensive data, unique intelligence, and exclusive access to ThoughtLeader analysis.
-
Data collection is driven by standing global cancer clinician panels in both the U.S. & Europe who record and report on their daily treatment activity, prescription selections and decision rationale.
-
Information and intelligence is augmented by clinician data sourcing that delivers >10% of global cancer clinicians.
-
ThoughtLeader advisers have contractually committed with MDoutlook™ to review the targeted cancer landscape, and all clinician-provided treatment data - in order to deliver their exclusive market and product specific intelligence via monthly reports and dedicated live forums.
For more information, please contact us here.
December 6th, 2007
Interview by Marylyn Donahue of Pharmaceutical Executive about the challenges facing the pharmaceutical and biotech industry, and what areas of focus would help to overcome these challenges. You can read our contributions by clicking here. For a copy of the entire article, please use this link.
December 6th, 2007
It is my great pleasure to welcome Craig Krugman to The Arcas Group. Craig joins this week as Vice President, Client Services and Strategy with a highly valued background. He will be a valued member of our Leadership team.
With more than 15 years in client services positions with different providers to the pharmaceutical and biotech industry, and close to 30 years experience in marketing, communication and relationship management, Craig brings relevant, tangible and fresh insights to addressing strategic and relationship management questions.
Craig joins Arcas at an exciting and defining time in its existence and we look forward to serving our clients even better. His bio can be found here.
Jan
August 5th, 2007
Previous Posts
